Experimental Drug May Help Multiple Sclerosis Patients Walk
Some 400,000 Americans suffer from multiple sclerosis, and each week another 200 people are diagnosed with the neurological condition.
While there’s no cure for MS, the treatment options have grown in the last decade or so, with the approval of drugs including Avonex from Biogen Idec, Tysabri from Biogen and Elan, and Copaxone from Teva.
(more…)